US
RJ Reynolds is seeking US Food and Drug Administration (FDA) approval that its e-cigarette Vuse is safer than traditional cigarettes.
Vuse, the second-best-selling e-cigarette in the US, was submitted for premarket approval from FDA in October. Approval requires FDA to consider a product’s risks and benefits, particularly when compared to traditional cigarettes.
RJ Reynolds is requesting permission to market Vuse as an electronic nicotine delivery system aimed at adult consumers.
Ricardo Oberlander, chief executive of Reynolds American Inc, said, “This is a first-of-its-kind application for Vuse products, and it puts Vuse one step closer to gaining a marketing order from the FDA. FDA will now review our scientific justification and determine the appropriateness of Vuse e-cigarette products against the public health standard.”